Drug Shortage Report for ENGERIX-B

Last updated on 2019-12-10 History
Report ID 6511
Drug Identification Number 01919431
Brand name ENGERIX B INJ SUS 20MCG/ML
Common or Proper name Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 20MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-04-06
Estimated end date
Actual end date 2019-12-09
Shortage status Resolved
Updated date 2019-12-10
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v55 2019-12-10 French Compare
v54 2019-12-10 French Compare
v53 2019-12-10 English Compare
v52 2019-11-25 French Compare
v51 2019-11-25 English Compare
v50 2019-11-01 French Compare
v49 2019-11-01 English Compare
v48 2019-10-18 French Compare
v47 2019-10-18 English Compare
v46 2019-07-10 French Compare
v45 2019-07-10 English Compare
v44 2019-04-18 French Compare
v43 2019-04-18 English Compare
v42 2019-03-08 French Compare
v41 2019-03-08 English Compare
v40 2019-02-08 French Compare
v39 2019-02-08 English Compare
v38 2019-01-25 French Compare
v37 2019-01-25 English Compare
v36 2019-01-23 French Compare

Showing 1 to 20 of 55